Participants in the trial will be grouped into three cohorts to receive one dose of the nasal spray vaccine at varying dosages. Credit: The NIAID Integrated Research Facility (IRF) in Fort Detrick, Maryland / National Institutes of Health. The US National Institutes of Health (NIH) has announced the start of subject enrolment for a Phase I clinical trial of MPV/S-2P, an investigational nasal vaccine designed to provide broader protection against evolving variants of SARS-CoV-2. A total of 60 subjects aged between 18 and 64 years will be enrolled at Baylor College of Medicine in Texas, the Hope Clinic of Emory Unive
Hence then, the article about nih announces start of subject enrolment for nasal covid 19 vaccine trial was published today ( ) and is available oncanadian news today ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( NIH announces start of subject enrolment for nasal Covid-19 vaccine trial )